Deep learning and multi-omics approach to predict drug responses in cancer

BACKGROUND: Cancers are genetically heterogeneous, so anticancer drugs show varying degrees of effectiveness on patients due to their differing genetic profiles. Knowing patient’s responses to numerous cancer drugs are needed for personalized treatment for cancer. By using molecular profiles of canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Conghao, Lye, Xintong, Kaalia, Rama, Kumar, Parvin, Rajapakse, Jagath C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703655/
https://www.ncbi.nlm.nih.gov/pubmed/36443676
http://dx.doi.org/10.1186/s12859-022-04964-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703655/
https://www.ncbi.nlm.nih.gov/pubmed/36443676
http://dx.doi.org/10.1186/s12859-022-04964-9

Ejemplares similares